World's Best Scientists 2026 revealed!
Lars A. Akslen

Lars A. Akslen

D-Index & Metrics

Medicine

D-Index
93
Citations
58426
World Ranking
10651
National Ranking
45

Lars A. Akslen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lars A. Akslen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 433 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Lars A. Akslen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lars A. Akslen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 93 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Lars A. Akslen is affiliated with the University of Bergen in Norway. Their research spans multiple fields including Medicine and Biochemistry, Genetics and Molecular Biology, with a strong focus on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, and Immunology.

Their work covers various main topics, particularly:

  • Breast Cancer Treatment Studies
  • Cancer Cells and Metastasis
  • Angiogenesis and VEGF in Cancer
  • Cancer Genomics and Diagnostics
  • Global Cancer Incidence and Screening
  • Prostate Cancer Treatment and Research
  • AI in cancer detection

Frequent publication venues for Akslen include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Pathology Clinical Research
  • Breast Cancer Research and Treatment
  • Scientific Reports
  • EBioMedicine

Coauthors regularly collaborating with Akslen are:

  • Elisabeth Wik
  • Gøril Knutsvik
  • Cecilie Askeland
  • Ole J. Halvorsen
  • Dimitrios Kleftogiannis

Examples of recent papers include:

  • Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility, 2020, Nature Genetics
  • AXL Targeting Abrogates Autophagic Flux and Induces Immunogenic Cell Death in Drug-Resistant Cancer Cells, 2020, Journal of Thoracic Oncology
  • Exploring the effects of lifestyle on breast cancer risk, age at diagnosis, and survival: the EBBA-Life study, 2020, Breast Cancer Research and Treatment
  • A novel age-related gene expression signature associates with proliferation and disease progression in breast cancer, 2022, British Journal of Cancer
  • Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus, 2022, Frontiers in Cellular and Infection Microbiology

Best Publications

  • Molecular portraits of human breast tumours

    Charles M. Perou;Therese Sørlie;Michael B. Eisen;Matt van de Rijn

  • Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

    Torsten O. Nielsen;Forrest D. Hsu;Kristin Jensen;Maggie Cheang

  • Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

    Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks

  • Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer

    William D. Foulkes;Ingunn M. Stefansson;Pierre O. Chappuis;Louis R. Bégin

  • EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast

    Ingeborg M. Bachmann;Ole J. Halvorsen;Karin Collett;Ingunn M. Stefansson

  • Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

    Turid Aas;Anne Lise Børresen;Stephanie Geisler;Birgitte Smith-Sørensen

  • Landscape of genomic alterations in cervical carcinomas

    Akinyemi I. Ojesina;Lee Lichtenstein;Samuel S. Freeman;Chandra Sekhar Pedamallu

  • A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer.

    Karsten Gravdal;Ole J. Halvorsen;Svein A. Haukaas;Lars A. Akslen

  • Role of Angiogenesis in Human Tumor Dormancy: Animal Models of the Angiogenic Switch

    George N. Naumov;Lars A. Akslen;Judah Folkman

  • Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes.

    Emad A. Rakha;Somaia E. Elsheikh;Somaia E. Elsheikh;Muhammed A. Aleskandarany;Muhammed A. Aleskandarany;Hany O. Habashi;Hany O. Habashi

  • Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival.

    Christine Gjerdrum;Crina Tiron;Torill Høiby;Ingunn Stefansson

  • A Model of Human Tumor Dormancy: An Angiogenic Switch From the Nonangiogenic Phenotype

    George N. Naumov;Elise Bender;David Zurakowski;Soo-Young Kang

  • Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

    Marc Tischkowitz;Marc Tischkowitz;Jean-Sébastien Brunet;Jean-Sébastien Brunet;Louis R. Bégin;David G. Huntsman

  • The Prognostic Implication of the Basal-Like (Cyclin Ehigh/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of BRCA1-Related Breast Cancer

    William D. Foulkes;Jean-Sébastien Brunet;Ingunn M. Stefansson;Oddbjørn Straume

  • Influence of TP53 gene alterations and c-erbB-2 expression on the response to treatment with doxorubicin in locally advanced breast cancer.

    Stephanie Geisler;Per Eystein Lønning;Turid Aas;Hilde Johnsen

  • Drug-sensitive FGFR2 mutations in endometrial carcinoma

    Amit Dutt;Helga B. Salvesen;Tzu-Hsiu Chen;Alex H. Ramos

  • PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma.

    Helga B. Salvesen;Helga B. Salvesen;Nicola MacDonald;Andy Ryan;Ian J. Jacobs

  • Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance

    George N. Naumov;Monique B. Nilsson;Tina Cascone;Alexandra Briggs

  • Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer

    Karin Collett;Geir E Eide;Jarle Arnes;Ingunn M Stefansson

  • RESPONSE: Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer

    William D. Foulkes;Lars A. Akslen

Frequent Co-Authors

Helga B. Salvesen
Helga B. Salvesen Haukeland University Hospital
Anders Molven
Anders Molven University of Bergen
William D. Foulkes
William D. Foulkes McGill University
Per Eystein Lønning
Per Eystein Lønning Haukeland University Hospital
Johan R. Lillehaug
Johan R. Lillehaug University of Bergen
Nicholas K. Hayward
Nicholas K. Hayward QIMR Berghofer Medical Research Institute
Anne Lise Børresen-Dale
Anne Lise Børresen-Dale Oslo University Hospital
Susana Puig
Susana Puig University of Barcelona
Rameen Beroukhim
Rameen Beroukhim Harvard University
Matthew Meyerson
Matthew Meyerson Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in medicine, various online degree options can open up alternative or complementary career pathways in healthcare. For those passionate about wellness and healthy living, online degrees in nutrition provide the skills needed to guide individuals and communities toward better health through diet and lifestyle improvements.

For leadership roles within hospitals and clinics, cahme accredited online healthcare administration programs equip students with advanced knowledge in management, policy, and finance. Nurses aiming to advance their qualifications can benefit from online rn to bsn programs no clinicals, which offer flexible options for earning a BSN without the need for additional clinical hours.

Those aspiring to reach the highest levels of nursing practice may consider short dnp programs, which provide a fast-track route to a Doctor of Nursing Practice degree. These online pathways offer flexibility, allow for ongoing professional work, and help address the growing need for healthcare professionals in the USA.

Best Scientists Citing Lars A. Akslen

Trending Scientists

Recently Published Articles